Similar articles

• The short form of RON is expressed in acute myeloid leukemia and sensitizes leukemic cells to cMET inhibitors.

  Fialin C, Larrue C, Vergez F, Sarry JE, Bertoli S, Mansat-De Mas V, Demur C, Delabesse E, Payrastre B, Manenti S, Roche S, Récher C. Fialin C, et al. Leukemia. 2013 Feb;27(2):325-35. doi: 10.1038/leu.2012.240. Epub 2012 Aug 20. Leukemia. 2013. PMID: 22902361
• Molecular biological characteristics of the recruitment of hematopoietic stem cells from bone marrow niche in chronic myeloid leukemia.

  Zhu B, Zhang J, Chen J, Li C, Wang X. Zhu B, et al. Int J Clin Exp Pathol. 2015 Oct 1;8(10):12595-607. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26722450 Free PMC article.
• The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.

  Brenner AK, Andersson Tvedt TH, Bruserud Ø. Brenner AK, et al. Molecules. 2016 Nov 11;21(11):1512. doi: 10.3390/molecules21111512. Molecules. 2016. PMID: 27845732 Free PMC article. Review.
• Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia.

  Prijić S, Ugrina I, Labar B, Nemet D, Batinić J, Zadro R, Ries S, Gjadrov-Kuvedžić K, Davidović S, Batinić D. Prijić S, et al. Leuk Lymphoma. 2015;56(8):2281-8. doi: 10.3109/10428194.2014.990012. Epub 2014 Dec 29. Leuk Lymphoma. 2015. PMID: 25426669
• [Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells].

  Zhang YC, Cheng T, Yuan WP. Zhang YC, et al. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):245-9. doi: 10.7534/j.issn.1009-2137.2013.01.050. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 23484729 Review. Chinese.